These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 36747082)

  • 21. Clinical Significance of Disulfidptosis-related Genes and Functional Analysis in Gastric Cancer.
    Yan J; Fang Z; Shi M; Tu C; Zhang S; Jiang C; Li Q; Shao Y
    J Cancer; 2024; 15(4):1053-1066. PubMed ID: 38230212
    [No Abstract]   [Full Text] [Related]  

  • 22. Pan-cancer genetic analysis of disulfidptosis-related gene set.
    Liu H; Tang T
    Cancer Genet; 2023 Nov; 278-279():91-103. PubMed ID: 37879141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigating the prognostic value of constructing disulfidptosis-related gene models for lung adenocarcinoma patients.
    Luo M; Liu RZ; Li YJ; Zhang SD; Wu ZY
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9569-9585. PubMed ID: 37916324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NFATc1-mediated expression of SLC7A11 drives sensitivity to TXNRD1 inhibitors in osteoclast precursors.
    Zhong Z; Zhang C; Ni S; Ma M; Zhang X; Sang W; Lv T; Qian Z; Yi C; Yu B
    Redox Biol; 2023 Jul; 63():102711. PubMed ID: 37148740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular subtypes of disulfidptosis-regulated genes and prognosis models for predicting prognosis, tumor microenvironment infiltration, and therapeutic response in hepatocellular carcinoma.
    Qu J; Guan H; Zheng Q; Sun F
    Int J Biol Macromol; 2024 Mar; 261(Pt 1):129584. PubMed ID: 38246443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-talk between disulfidptosis and immune check point genes defines the tumor microenvironment for the prediction of prognosis and immunotherapies in glioblastoma.
    Zhou Y; Qin X; Hu Q; Qin S; Xu R; Gu K; Lu H
    Sci Rep; 2024 Feb; 14(1):3901. PubMed ID: 38365809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring the role of the disulfidptosis-related gene SLC7A11 in adrenocortical carcinoma: implications for prognosis, immune infiltration, and therapeutic strategies.
    Liu T; Ren Y; Wang Q; Wang Y; Li Z; Sun W; Fan D; Luan Y; Gao Y; Yan Z
    Cancer Cell Int; 2023 Nov; 23(1):259. PubMed ID: 37919768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disulfidptosis and its Role in Peripheral Blood Immune Cells after a Stroke: A New Frontier in Stroke Pathogenesis.
    Liu SP; Liu C; Xu B; Zhou H; Zhao H
    Curr Neurovasc Res; 2024; 20(5):608-622. PubMed ID: 38299279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy.
    Koppula P; Zhuang L; Gan B
    Protein Cell; 2021 Aug; 12(8):599-620. PubMed ID: 33000412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction of a novel disulfidptosis-related signature for improving outcomes in hepatocellular carcinoma: Observational study.
    Chen X; Liang Q; Zhou Y
    Medicine (Baltimore); 2023 Oct; 102(40):e35423. PubMed ID: 37800779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated analysis of disulfidptosis-related immune genes signature to boost the efficacy of prognostic prediction in gastric cancer.
    Li J; Yu T; Sun J; Ma M; Zheng Z; He Y; Kang W; Ye X
    Cancer Cell Int; 2024 Mar; 24(1):112. PubMed ID: 38528532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identifying disulfidptosis subtypes in hepatocellular carcinoma through machine learning and preliminary exploration of its connection with immunotherapy.
    Chen G; Zhang G; Zhu Y; Wu A; Fang J; Yin Z; Chen H; Cao K
    Cancer Cell Int; 2024 Jun; 24(1):194. PubMed ID: 38831301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment of disulfidptosis-related LncRNA signature as biomarkers in colon adenocarcinoma.
    Yao H; Liu P; Yao L; Li X
    Cancer Cell Int; 2024 May; 24(1):183. PubMed ID: 38802854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PPARγ Antagonists Exhibit Antitumor Effects by Regulating Ferroptosis and Disulfidptosis.
    Zhang S; Wang Y; Gu J; Yang Y; Liang J; Wang Y; Ji N; Liu M; Zhang Y; Sun S; Chen Q; Li J
    Biomolecules; 2024 May; 14(5):. PubMed ID: 38786003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disulfidptosis: Disulfide Stress Mediates a Novel Cell Death Pathway via Actin Cytoskeletal Vulnerability.
    Shao D; Shi L; Ji H
    Mol Cells; 2023 Jul; 46(7):414-416. PubMed ID: 37431161
    [No Abstract]   [Full Text] [Related]  

  • 36. Integrating bulk-seq and single-cell-seq reveals disulfidptosis potential index associating with neuroblastoma prognosis and immune infiltration.
    Zhu A; Li X; Wang J
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16647-16658. PubMed ID: 37721569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disulfidptosis-related gene expression reflects the prognosis of drug-resistant cancer patients and inhibition of MYH9 reverses sorafenib resistance.
    Zhang K; Zhu Z; Zhou J; Shi M; Wang N; Yu F; Xu L
    Transl Oncol; 2024 Nov; 49():102091. PubMed ID: 39146597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated machine learning-driven disulfidptosis profiling: CYFIP1 and EMILIN1 as therapeutic nodes in neuroblastoma.
    Mengzhen Z; Xinwei H; Zeheng T; Nan L; Yang Y; Huirong Y; Kaisi F; Xiaoting D; Liucheng Y; Kai W
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):109. PubMed ID: 38427078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of a disulfidptosis and disulfide metabolism-related risk index for predicting prognosis in lung adenocarcinoma.
    Zhong L; Chang W; Luo B; Gao W; He H; Fang M; Li H; Wen Z; Chen Y
    Cancer Cell Int; 2024 Jan; 24(1):2. PubMed ID: 38167017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring the role of disulfidptosis-related signatures in immune microenvironment, prognosis and therapeutic strategies of cervical cancer.
    Jin T; Yin T; Xu R; Liu H; Yuan S; Xue Y; Zhang J; Wang H
    Transl Oncol; 2024 Jun; 44():101938. PubMed ID: 38492499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.